8-K 1 fonar_8-k.htm FONAR 8-K 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Act of 1934

 

Date of Report (Date of earliest event reported): February 11, 2019

 

FONAR CORPORATION

______________________________________________________

(Exact name of registrant as specified in its charter)

 

Delaware  0-10248  11-2464137
(State or other jurisdiction of incorporation)  (Commission File Number)  (I.R.S. Employer Identification No.)
   110 Marcus Drive
Melville, New York 11747
(631) 694-2929
   
   (Address, including zip code, and telephone number of registrant's principal executive office)   

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act 17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

Item 2.02(a) Results of Operations and Financial Condition.

 

We reported the results of operations and financial condition of the Company for the six month period and fiscal quarter ended December 31, 2018 in a press release dated February 11, 2019.

 

Exhibits

 

99.1 Press Release dated February 11, 2019

  

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

FONAR CORPORATION

(Registrant)

 

---------------------------------------------

By /s/ Timothy R. Damadian

Timothy R. Damadian

President and CEO

Dated: February 12, 2019